Orencia and Rituxan are currently the main players in the TNF-failure setting, and MM-093 will almost certainly be more tolerable than either of them. The question is whether it will be as efficacious.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”